Nexletol was approved for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol.
, but the medicines don’t lower LDL cholesterol enough for many patients and others experience side effects such as muscle pain. Other options include Zetia pills, also sold in generic form as ezetimibe for about $13 to $50 a month.
Far fewer patients use Repatha and Praluent, newer drugs that cost $6,000 or more a year. Insurers often restrict coverage of those medicines, which are shots patients give themselves once or twice a month. Esperion, based in Ann Arbor, Michigan, did not immediately disclose the drug's list price but previously said it planned a price of about $300 per month. Nexletol, also known as bempedoic acid, should be available in late March, the company said.
It works in the liver by blocking an enzyme needed to make LDL. Statins also block cholesterol production in the liver, but in a different way, so the drugs together can reduce LDL more. The new drug “would be valuable to add to treatment” for patients who can't get their LDL down enough with existing drugs or can't afford the injected ones, Duke Heart Center co-director Dr. Manesh Patel said. Patel, who was not involved in the research, estimated 10% to 15% of his patients might be eligible for Nexletol.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA Clears New Type of Cholesterol DrugAmericans struggling to lower their cholesterol will have another drug at their disposal, after the FDA approved a new medicine from Esperion Therapeutics.
Les mer »
FDA Clears New Type of Cholesterol DrugAmericans struggling to lower their cholesterol will have another drug at their disposal, after the FDA approved a new medicine from Esperion Therapeutics.
Les mer »
Twitter is testing new ways to fight misinformation — including a community-based points systemA leaked demo features bright red and orange badges for tweets that have been deemed “harmfully misleading."
Les mer »
NFL's proposal for players includes 17-game season, pay increases, limited THC testingNFL owners approved a new collective bargaining agreement proposal with increases to pay and limited THC testing, according to terms released on the league's website.
Les mer »